Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.4K
2.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Influence of Chemical Exposures in Breast Cancer Disparities: High-Throughput Transcriptomic Analysis in Normal Breast Cells from Diverse Donors.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.

Nature immunology·2026
Same author

Dynamic Immune Cell Composition, Phenotypes, and Signaling in an Engineered Metastatic Niche.

Biotechnology and bioengineering·2026
Same author

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

NPJ precision oncology·2025
Same author

Correction: Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy.

International journal of biological sciences·2025

Related Experiment Video

Updated: Apr 14, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.

Qin Pan1,2, Qiao Li1, Shuang Liu3

  • 1University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

Stem Cells (Dayton, Ohio)
|April 16, 2015
PubMed
Summary

Cancer stem cells (CSCs) are resistant to traditional treatments. Novel immunotherapies targeting CSCs and their niche show promise for improving cancer treatment efficacy and preventing recurrence.

Keywords:
Cancer stem cellsCytotoxic T lymphocytesImmunotherapyLymphocytes

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Stem Cell Biology

Background:

  • Cancer stem cells (CSCs) drive tumor recurrence and metastasis.
  • CSCs exhibit resistance to conventional chemotherapy and radiotherapy.
  • Targeting CSCs is crucial for effective cancer therapy.

Purpose of the Study:

  • To review novel immunotherapeutic strategies for targeting cancer stem cells (CSCs).
  • To explore the potential of innate and adaptive immune responses against CSCs.
  • To identify CSC-specific targets and therapeutic approaches.

Main Methods:

  • Review of current research on CSC immunotherapies.
  • Analysis of innate immune cell (NK, γδ T cells) roles in targeting CSCs.
  • Evaluation of adoptive T cell transfer and dendritic cell vaccines for CSC targeting.
  • Discussion of CSC-specific antigens (ALDH, CD44, CD133, HER2) and niche interactions as targets.

Main Results:

  • In vitro generated CSC-primed T cells demonstrate in vivo CSC targeting.
  • CSC-based dendritic cell vaccines induce significant anti-CSC immunity.
  • Identified CSC markers and niche interactions offer potential therapeutic targets.
  • Targeting tumor microenvironment components enhances CSC immunotherapy.

Conclusions:

  • Novel immunotherapies offer promising strategies to overcome CSC resistance.
  • Targeting CSCs, their antigens, and niche interactions can improve cancer treatment outcomes.
  • Further research into CSC-specific immunotherapy is warranted to enhance efficacy and prevent metastasis.